Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




3D Network Structures Improve Survival of Transplanted Stem Cell-Derived Neurons

By LabMedica International staff writers
Posted on 27 Mar 2016
Neurological disease researchers have developed a method for treating neurodegenerative diseases such as Parkinson's by transplanting three-dimensional (3D) networks of stem cell-derived neurons into the damaged brain tissue.

Cell replacement therapy using human pluripotent stem cell-derived neurons has the potential to correct neurodegenerative damage and central nervous system injuries, but transplantation of dissociated and spatially disorganized neurons portends poor cell survival and incomplete functional development.

Investigators at Rutgers University (Piscataway, NJ, USA) and Stanford University (Palo Alto, CA, USA) recently described the design of three-dimensional scaffolds based on tunable electrospun microfibrous polymeric substrates. More...
These scaffolds promoted in situ stem cell neuronal reprogramming, neural network establishment, and supported neuronal engraftment into the brain.

The investigators reported in the March 17, 2016, online edition of the journal Nature Communications that they had successfully grafted scaffold-supported, reprogrammed neuronal networks into organotypic hippocampal brain slices. This approach yielded an approximately 3.5-fold improvement in neurite outgrowth and increased action potential firing relative to injected isolated cells. Transplantation of scaffold-supported neuronal networks into mouse brain striatum improved survival by about 38-fold at the injection site relative to injected isolated cells, and allowed delivery of multiple neuronal subtypes.

"If you can transplant cells in a way that mimics how these cells are already configured in the brain, then you are one step closer to getting the brain to communicate with the cells that you are now transplanting," said senior author Dr. Prabhas V. Moghe, professor of biomedical, chemical, and biochemical engineering at Rutgers University. "In this work, we have done that by providing cues for neurons to rapidly network in three dimensions."

Related Links:

Rutgers University
Stanford University



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.